To verify if the ACh-synthesizing enzyme may upload the steady-state equilibrium of ACh levels, balancing the actions of higher cholinesterases, in RR-MS patients and HD subjects we evaluated the expression of the transcript for the ACh biosynthetic enzyme choline acetyltransferase (ChAT). This evidence concerns the gene FGFR3 and myeloid sarcoma.